References and Notes
-
1a
Lewis JR.
Nat. Prod. Rep.
2001,
18:
95
-
1b
O’Hagan D.
Nat. Prod. Rep.
2000,
17:
435
- 2
Fache F.
Schulz E.
Tommasino ML.
Lemaire M.
Chem. Rev.
2000,
100:
2159
-
For select recent examples, see:
-
3a
Fish PV.
Andrews MD.
Fray MJ.
Stobie A.
Wakenhut F.
Whitlock GA.
Bioorg.
Med. Chem. Lett.
2009,
19:
2829
-
3b
Fish PV.
Fray MJ.
Stobie A.
Wakenhut F.
Whitlock GA.
Bioorg. Med. Chem. Lett.
2007,
17:
2022
-
3c
Kohrt JT.
Bigge CF.
Bryant JW.
Casimiro-Garcia A.
Chi L.
Cody WL.
Dahring T.
Dudley DA.
Filipski KJ.
Haarer S.
Heemstra R.
Janiczek N.
Narasimhan L.
McClanahan T.
Peterson JT.
Sahasrabudhe V.
Schaum R.
Van Huis CA.
Welch KM.
Zhang E.
Leadley
RJ.
Edmunds JJ.
Chem. Biol. Drug
Des.
2007,
70:
100
-
For recent reviews, see:
-
4a
Coldham I.
Hufton R.
Chem. Rev.
2005,
105:
2765
-
4b
Pandey G.
Banerjee P.
Gadre SR.
Chem.
Rev.
2006,
106:
4484
- 5
Padwa A.
Dent W.
J. Org. Chem.
1987,
52:
235
- 6
Lown JW.
1,3-Dipolar Cycloaddition Chemistry
Vol.
1:
Padwa A.
Wiley;
New
York:
1984.
Chap. 6.
- 7
Beugelmans R.
Negron G.
Roussi G.
J.
Chem. Soc., Chem. Commun.
1983,
31
-
8a
Beugelmans R.
Benadjila-Iguertsira L.
Chastanet J.
Negron G.
Roussi G.
Can. J. Chem.
1985,
63:
725
-
8b
Beugelmans R.
Chastanet J.
Roussi G.
Heterocycles
1987,
26:
3197
-
8c
Beugelmans R.
Chastanet J.
Roussi G.
Heterocycles
1987,
26:
3197
-
10a
De B..
DeBernardis JF.
Prasad R.
Synth. Commun.
1988,
18:
481
-
10b
Negron G.
Calderon G.
Vazquez F.
Lomas L.
Cardenas J.
Marquez C.
Gavino R.
Synth. Commun.
2002,
32:
1977
-
10c Kemperman GJ, Stuk
TL, and Van Der Linden JJM. inventors; WO2008003460.
- 11
Olofson RA.
Martz JT.
Senet JP.
Piteau M.
Malfroot T.
J.
Org. Chem.
1984,
49:
2081
9
Representative
Procedure
Commercial LDA (2.5 M in THF, 3.1 mL, 4.7
mmol, 4.5 equiv) was added to a solution of (E)-1,2-dimethoxy-4-styrylbenzene
(250 mg, 1.0 mmol, 1 equiv) and trimethyl-amine N-oxide 4 (117 mg, 1.6 mmol, 1.5 equiv) in anhyd THF
(10 mL) at 0 ˚C. After 1 h, the reaction was quenched with
H2O and extracted with EtOAc. The combined organic layers
were dried (Na2SO4) and concentrated under
reduced pressure. The crude residue was purified by flash chroma-tography
eluting with CH2Cl2-MeOH (95:5) to
give 285 mg (92%) of trans-3,4-disubstituted
pyrrolidine 8 as a yellow oil: ¹H
NMR (400 MHz, CDCl3): δ = 7.26-7.12
(m, 5 H), 6.75-6.70 (m, 2 H), 6.68 (s, 1 H), 3.81 (s, 3
H), 3.78 (s, 3 H), 3.36-3.26 (m, 2 H), 3.12-3.06
(m, 2 H), 2.87-2.80 (m, 2 H), 2.44 (s, 3 H) ppm. LC-MS: m/z = 298.1 [M + 1].
12
Representative
Procedure
A solution of N-methylpyrrolidine 8 (255 mg, 0.9 mmol) in neat ACE-Cl (3
mL) was irradiated in a microwave reactor at 170 ˚C
for 30 min. MeOH (3 mL) was added to the mixture and thermally refluxed
for an additional 1 h. The crude reaction mixture was purified by
ion exchange on a MP-TsOH column to give 51 mg (21%) of
pyrrolidine 11 as a pale yellow oil: ¹H
NMR (400 MHz, CDCl3): δ = 7.26-7.20
(m, 2 H), 7.18-7.12 (m, 3 H), 6.73-6.70 (m, 1
H), 6.70-6.66 (m, 1 H), 6.62 (d, J = 2.0
Hz, 1 H), 3.79 (s, 3 H), 3.75 (s, 3 H), 3.66-3.54 (m, 2
H), 3.35-3.25 (m, 2 H), 3.24-3.14 (m, 2 H), 2.62
(br s, 1 H) ppm. LC-MS: m/z = 284.0 [M + 1].